Search

129 results for “severity”

• Case ReportOpen Access

  A case of tinnitus induced by chlorpromazine in a pediatric patient

  Carla Carnovale, Paolo Pellegrino, Silvia Beretta, Gian Vincenzo Zuccotti, Valentina Perrone, Stefania Antoniazzi, Marco Pozzi, Emilio Clementi, Sonia Radice

  Vol. 5 · Issue 2 · pp. 163–165

  https://doi.org/10.4103/0976-500X.130110
  Full text ↗PDF

• Case ReportOpen Access

  Amniotic fluid volume changes in response to frusemide induced maternal fluid shifts

  K. Manikandan, S. Raghavan

  Vol. 5 · Issue 2 · pp. 153–154

  https://doi.org/10.4103/0976-500X.130075
  Full text ↗PDF

• Research PaperOpen Access

  Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reports

  Ilma Bertulyte, Sofie Schwan, Pär Hallberg

  Vol. 5 · Issue 2 · pp. 100–138

  https://doi.org/10.4103/0976-500X.130051
  Full text ↗PDF

• Case ReportOpen Access

  Acute delirium in an elderly woman following zoledronate administration

  Mohammad Nasiruddin, Mohd Fayazuddin, Mohammad Zahid, Syed Iftekhar

  Vol. 5 · Issue 3 · pp. 217–219

  https://doi.org/10.4103/0976-500X.136115
  Full text ↗PDF

• Case ReportOpen Access

  Periodic paralysis: An unusual presentation of drug‑induced hyperkalemia

  Poonam Agrawal, Deepti Chopra, Surajeet K. Patra, Himanshu Madaan

  Vol. 5 · Issue 1 · pp. 63–64

  https://doi.org/10.4103/0976-500X.124429
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Sofosbuvir: A novel treatment option for chronic hepatitis C infection

  Harmeet Kaur Bhatia, Harmanjit Singh, Nipunjot Grewal, Navreet Kaur Natt

  Vol. 5 · Issue 4 · pp. 278–284

  https://doi.org/10.4103/0976-500X.142464
  Full text ↗PDF

• Research PaperOpen Access

  Nephrotoxicity of cefepime: A new cephalosporin antibiotic in rats

  Mossad Gamaleddin Ahmed Elsayed, Ashraf Abdelhakim Ahmed Elkomy, Mahmoud Salem Gaballah, Mohamed Elbadawy

  Vol. 5 · Issue 1 · pp. 33–33

  https://doi.org/10.4103/0976-500X.124419
  Full text ↗PDF

• EditorialOpen Access

  Push, promote or educate…musings of a pharmacologist on drug promotion

  Chanolean Shashindran

  Vol. 5 · Issue 4 · pp. 225–226

  https://doi.org/10.4103/0976-500X.142427
  Full text ↗PDF

• Research PaperOpen Access

  Assessment of demographics, treatment strategies, and evidence‑based medicine use among diabetic and non‑diabetic patients with acute coronary syndrome: A cohort study

  Bhavik S. Shah, Shrikalp S. Deshpande

  Vol. 5 · Issue 2 · pp. 139–144

  https://doi.org/10.4103/0976-500X.130058
  Full text ↗PDF

• Case ReportOpen Access

  Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine

  Andreu Massot, Ana Gimenez-Arnau

  Vol. 5 · Issue 4 · pp. 271–274

  https://doi.org/10.4103/0976-500X.142456
  Full text ↗PDF

• CommentaryOpen Access

  Informatics applied to pharmacovigilance: Future perspectives

  Michele Menniti, Annamaria Menniti, Marinella Patanè, Stefania Esposito, Chiara Giofrè, Rossana Aiello, Emilio Russo

  Vol. 4 · Issue 1 · pp. S43–S44

  https://doi.org/10.4103/0976-500X.120950
  Full text ↗PDF

• Case ReviewOpen Access

  Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review

  Christian Leporini, Francesca Saullo, Gianfranco Filippelli, Antonio Sorrentino, Maria Lucia, Gino Perri, Gaetana Gattuta, Stefania Infusino, Rosa Toscano, Gianluca Dima, Virginia Olivito, Laura Paletta, Ugo Bottoni, Giovambattista Sarro

  Vol. 4 · Issue Supplement 1 · pp. S78–S79

  https://doi.org/10.4103/0976-500X.120966
  Full text ↗PDF

• Case ReviewOpen Access

  Corticosteroid-related central nervous system side effects

  Miriam Ciriaco, Pasquale Ventrice, Gaetano Russo, Maria Scicchitano, Giovanni Mazzitello, Francesca Scicchitano, Emilio Russo

  Vol. 4 · Issue Supplement 1 · pp. S94–S95

  https://doi.org/10.4103/0976-500X.120975
  Full text ↗PDF

• Review ArticleOpen Access

  Clinical and economic burden of adverse drug reactions

  Janet Sultana, Paola Cutroneo, Gianluca Trifirò

  Vol. 4 · Issue 1 · pp. S73–S74

  https://doi.org/10.4103/0976-500X.120957
  Full text ↗PDF

• Research LetterOpen Access

  Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model

  Masayuki Okamoto, Takeshi Suzuki, Nobuhide Watanabe

  Vol. 4 · Issue 3 · pp. 208–210

  https://doi.org/10.4103/0976-500X.114605
  Full text ↗PDF

• Mini ReviewOpen Access

  Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

  Pasquale Ventrice, Christian Leporini, Jose’ Francisco Aloe, Ettore Greco, Giacomo Leuzzi, Giuseppina Marrazzo, Giovanni Battista Scorcia, Donatella Bruzzichesi, Varano Nicola, Vincenzo Scorcia

  Vol. 4 · Issue Supplement 1 · pp. S38–S39

  https://doi.org/10.4103/0976-500X.120947
  Full text ↗PDF

• News and ViewsOpen Access

  Baldness, a new marker for coronary heart disease risk

  Sivagnanam G

  Vol. 4 · Issue 3 · pp. 223–224

  Full text ↗PDF

• Research LetterOpen Access

  Inadequate pain relief for patients with trauma: A cause for concern?

  Sadasivam Balakrishnan, Ratinder Jhaj, Vishnu Raj

  Vol. 4 · Issue 4 · pp. 281–281

  https://doi.org/10.4103/0976-500X.119714
  Full text ↗PDF

• EditorialOpen Access

  Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance

  Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. 1–3

  https://doi.org/10.4103/0976-500X.120938
  Full text ↗PDF

• Case ReviewOpen Access

  Vertigo/dizziness as a Drugs’ adverse reaction

  Serafina Chimirri, Rossana Aiello, Carmela Mazzitello, Laura Mumoli, Caterina Palleria, Mariolina Altomonte, Rita Citraro, Giovambattista Sarro

  Vol. 4 · Issue Supplement 1 · pp. S104–S105

  https://doi.org/10.4103/0976-500X.120969
  Full text ↗PDF